NeuroScientific Biopharmaceuticals Limited (ASX:NSB)
Australia · Delayed Price · Currency is AUD 0.0990
-0.0010 (-1.00%)
May 11, 2026, 9:59 AM AEST
ASX:NSB Market Cap
ASX:NSB has a market cap or net worth of 33.26 million as of May 8, 2026. Its market cap has increased by 557.11% in one year.
Market Cap
33.26M
Enterprise Value
26.90M
Revenue
317.91K
Ranking
n/a
PE Ratio
n/a
Stock Price
0.10
Market Cap Chart
Since July 27, 2018, ASX:NSB's market cap has increased from 16.56M to 33.26M, an increase of 100.88%. That is a compound annual growth rate of 9.37%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 33.26M | -9.09% |
| Dec 31, 2025 | 36.58M | 666.63% |
| Dec 30, 2024 | 4.77M | -25.00% |
| Dec 29, 2023 | 6.36M | -64.52% |
| Dec 29, 2022 | 17.93M | -62.69% |
| Dec 31, 2021 | 48.06M | 116.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Jul 27, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Entropy Neurodynamics | 59.56M |
| Prescient Therapeutics | 56.78M |
| Neurizon Therapeutics | 56.40M |
| Avecho Biotechnology | 47.76M |
| Imugene | 42.35M |
| EZZ Life Science Holdings | 29.42M |
| Proteomics International Laboratories | 28.91M |
| Algorae Pharmaceuticals | 26.30M |